SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

WEEDCOIN is trending following a retail frenzy fueled by discussions around recent federal cannabis reclassification, seen as a significant catalyst for the sector. The community highlights WEEDCOIN as the primary beneficiary and a leading cultural play within the Solana ecosystem, positioning it as an on-chain alternative to traditional pharmaceutical models. Sentiment emphasizes its potential for substantial growth as the "Green Wave" gains momentum.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is currently trending due to a surge in community engagement and speculative interest surrounding various meme coins building on its network, most notably "$WEEDCOIN." Enthusiasts are actively discussing the "Green Wave" narrative, portraying these assets as a significant catalyst and source of liquidity within Solana's high-speed and low-fee ecosystem. This robust activity highlights a vibrant, community-driven sentiment within the network's decentralized finance space.

SSgA Active Trust - SPDR Dow Jones Industrial Average ETF

The SPDR Dow Jones Industrial Average ETF ($DIA) is actively debated as strong US economic data, including robust GDP and softening inflation, fuels optimism for a year-end rally. However, community sentiment is split, with many cautioning against "inorganic" holiday trading and potential global liquidity shifts, while others see DIA as an old economy barometer confirming broader market strength or weakness.

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP Token is actively trending as discussions focus on its real-world utility through Flexa's expanding merchant network, enabling crypto payments at major retailers like Chipotle and Nordstrom. This visibility fuels optimism among long-term holders for future adoption and significant price recovery, contrasting with skepticism from those wary of past volatility and downward price trends. The community remains divided, debating whether current momentum signals a sustained uptrend or another fleeting pump.

Subsquid Network is an innovative decentralized data lake and query engine designed to offer developers performant and permissionless access to data, aiming to build a neutral and open internet rooted in Web3 principles. Secured by ZK proofs, the Subsquid network boasts a modular architecture that enables exceptional scalability and developer convenience optimized for blockchain indexing, dApp development, and analytics.  Subsquid is a response to unscalable and rigid monolithic indexing frameworks that had previously gained popularity and market traction among Web3 developers. Today, these frameworks are struggling to adapt in a rapidly evolving blockchain environment. Additionally, the network serves as a highly efficient and decentralized alternative to centralized infrastructure firms, including large RPC and API providers.

SQD is trending due to its pivotal role in Rezolve AI's integration of decentralized blockchain data with enterprise AI and digital payments, enhancing its utility across hundreds of blockchains. Community discussions are highly focused on the upcoming Tokenomics 2.0, which aims to drive sustainable value through usage-driven rewards and reduced token supply, igniting significant bullish sentiment.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is gaining attention for its expanding anticoagulation pipeline, highlighted by recent acquisitions and significant progress on its lead candidate, tecarfarin, including manufacturing readiness and a collaboration with Abbott. This "quiet expansion" is sparking community interest, with many anticipating a breakout given its low float and regulatory designations. However, skepticism persists among some regarding the company's financial stability and potential dilution.

TOSHI

TOSHI is trending with strong community conviction, fueled by its position as the "Face of Base" and ongoing anticipation for major exchange listings and ecosystem developments. Despite recent price volatility, supporters are actively accumulating, highlighting its expanding utility beyond meme status and prominent connection to the Coinbase ecosystem.

Ameriprise Financial, Inc. operates as a holding company. The firm provides financial planning, asset management and insurance services to individuals, businesses and institutions. It operates through the following business segments: Advice & Wealth Management, Asset Management, Retirement & Protection Solutions, and Corporate & Other. The Advice & Wealth Management segment provides financial planning and advice, as well as full-service brokerage and banking services, primarily to retail clients through the company's financial advisors. The Asset Management segment provides investment advice and investment products to retail and institutional clients. It also provides products and services on a global scale through two complementary asset management businesses: Columbia Management and Threadneedle. The Columbia Management business primarily provides U.S. domestic products and services and Threadneedle primarily provides international investment products and services. Its international retail products are primarily provided through third-party financial institutions. The segments retail products include mutual funds and variable product funds underlying insurance and annuity separate accounts. The Retirement & Protection Solutions segment offers a variety of protection products to address the protection and risk management needs of the company's retail clients, including life, DI, and property-casualty insurance. The Corporate & Other segment consists of net investment income on corporate level assets, including excess capital held in the company's subsidiaries and other unallocated equity and other revenues from various investments as well as unallocated corporate expenses. The company was founded by John Tappan in 1894 and is headquartered in Minneapolis, MN.

Ameriprise Financial Inc

Ameriprise Financial is trending amidst robust discussion, notably due to widespread user confusion with a similarly-named crypto token. For the actual NYSE-listed wealth manager, recent strong earnings, consistent growth in assets under management, and strategic advisor team acquisitions are driving positive sentiment. These business developments, coupled with a dividend increase and share repurchase authorization, are fueling community debate over its continued momentum in the financial sector.

Reactive Network is the first parallelized interoperability execution layer, utilising a new form of smart contract we call reactive smart contracts.   Reactive smart contracts are able to react to on-chain events autonomously and execute their own user defined logic to initiate new transactions. This allows a virtually limitless number of use cases to achieve fully decentralized on-chain automation.

Reactive Network

Reactive Network is actively trending following its role as the first project tested on Ethereum's new EIL testnet, an innovation poised to unify Layer 2 solutions. The community is buzzing about this foundational utility, alongside recent integrations for DeFi automation, AI strategies, and Real-World Assets (RWA) execution, viewing the project as a severely undervalued hidden gem. With the completion of its token migration expected to reduce arbitrage pressures, many anticipate significant upside as its advanced smart contract capabilities gain broader market recognition.

The Hartford Insurance Group, Inc. is an insurance and financial services company. It operates through the following segments: Commercial Lines, Personal Lines, Property & Casualty Other Operations, Group Benefits, Hartford Funds, and Corporate. The Commercial Lines segment provides workers' compensation, property, automobile, liability and umbrella coverage under several different products. The Personal Lines segment offers standard automobile, homeowners, and personal umbrella coverage to individuals. The Property & Casualty Other Operations segment includes certain property and casualty operations, managed by the company, that have discontinued writing new business and substantially all of the company's asbestos and environmental exposures. The Group Benefits segment provides group life, accident, and disability coverage, as well as group retiree health and voluntary benefits. The Hartford Funds segment offers investment products for retail and retirement accounts and provides investment management and administrative services. The Corporate segment includes corporate category discontinued operations, reserves for run-off structured settlement, and terminal funding agreement liabilities, restructuring costs, and capital raising activities. The company was founded by Terry Nathaniel on May 10, 1810, and is headquartered in Hartford, CT.

Hartford Insurance Group Inc.(The)

Hartford Financial Services Group Inc.

Hartford Financial is experiencing notable attention driven by its consistent strong earnings performance and a wave of positive analyst upgrades and price target revisions. The community highlights the company's disciplined execution, strategic investments in areas like cyber insurance, and capital return initiatives, contributing to a perception of HIG as a reliable, growth-oriented insurance play.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Agios Pharmaceuticals (AGIO) Surges 18.6%: Is This an Indication of Further Gains?

Agios Pharmaceuticals (AGIO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Receives Consensus Rating of "Moderate Buy" from Analysts

Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA - Get Free Report) have received an average recommendation of "Moderate Buy" from the seven research firms that are presently covering the firm...

Enanta Pharmaceuticals (ENTA) Surges 5.9%: Is This an Indication of Further Gains?

Enanta Pharmaceuticals (ENTA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Enanta Pharmaceuticals (NASDAQ:ENTA) Share Price Crosses Above 200-Day Moving Average - What's Next?

Enanta Pharmaceuticals (NASDAQ:ENTA) Stock Price Passes Above 200-Day Moving Average - Should You Sell...

Enanta Pharmaceuticals (NASDAQ:ENTA) Insider Scott Rottinghaus Sells 798 Shares

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA - Get Free Report) insider Scott Rottinghaus sold 798 shares of Enanta Pharmaceuticals stock in a transaction that occurred on Friday, December 5th. The...

Insider Selling: Enanta Pharmaceuticals (NASDAQ:ENTA) Insider Sells 1,394 Shares of Stock

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA - Get Free Report) insider Brendan Luu sold 1,394 shares of the company's stock in a transaction dated Friday, December 5th. The shares were sold at an...

Tara Lynn Kieffer Sells 2,106 Shares of Enanta Pharmaceuticals (NASDAQ:ENTA) Stock

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA - Get Free Report) insider Tara Lynn Kieffer sold 2,106 shares of the firm's stock in a transaction on Friday, December 5th. The stock was sold at an average...

Enanta Pharmaceuticals (NASDAQ:ENTA) Insider Sells $34,009.70 in Stock

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA - Get Free Report) insider Yat Sun Or sold 2,390 shares of Enanta Pharmaceuticals stock in a transaction that occurred on Friday, December 5th. The shares...

Enanta Pharmaceuticals (NASDAQ:ENTA) CEO Jay Luly Sells 4,743 Shares of Stock

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA - Get Free Report) CEO Jay Luly sold 4,743 shares of the business's stock in a transaction on Friday, December 5th. The stock was sold at an average price of...

Insider Selling: Enanta Pharmaceuticals (NASDAQ:ENTA) Insider Sells 798 Shares of Stock

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA - Get Free Report) insider Scott Rottinghaus sold 798 shares of the firm's stock in a transaction dated Friday, December 5th. The shares were sold at an...

Enanta Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. It produces clinical candidates which targets respiratory syncytial virus (RSV), hepatitis B virus (HBV), and non-alcoholic steatohepatitis (NASH) diseases. The firm also conducts research in human metapneumovirus (hMPV) and SARS-CoV-2 (COVID-19). The company was founded by Peter O. Kliem Martin Karplus, James Hogle, Gerard Wagner, Peter M. Howley, and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA.

Current Price	$15.77
Prev Close	$15.90
Open	$15.84
Dividend Yield	0.00%
50-Day Moving Average	$13.15
Beta	1.07
Avg. Volume	314,629.89
PE Ratio	-4.11

52-Week High	$17.15
52-Week Low	$4.09
Market Capitalization	$455.16M
EPS (Annual)	-$3.84
Price to Book	5.21
Revenue Per Employee	$544,366.67
Enterprise Value/EBITDA	N/A

ENTA
Enanta Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ENTA News

ENTAEnanta Pharmaceuticals Inc